Company Overview and News


Add AMED
to your dashboard

Headline News

Why Envision Healthcare (EVHC) Could Be Positioned for a Slump

2017-11-15 zacks
Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security before more losses hit your portfolio. (8-0)

Amedisys' (AMED) CEO Paul Kusserow on Q3 2017 Results - Earnings Call Transcript

2017-11-11 seekingalpha
Greetings and welcome to the Amedisys Third Quarter 2017 Earnings call. At this time all participants are in a listen only mode. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. David Castille. Thank you. You may begin. (7-0)

AMEDISYS Inc 2017 Q3 - Results - Earnings Call Slides

2017-11-10 seekingalpha
The following slide deck was published by AMEDISYS Inc in conjunction with their 2017 Q3 earnings call. (7-0)

Universal Health Services (UHS) Hits 52-Week Low on Dull Q3

2017-11-09 zacks
Shares of Universal Health Services Inc. (UHS - Free Report) tumbled to a 52-week low of $99.56 during the trading session on Nov 8. The slide is believed to have stemmed from poor third-quarter results and a subsequent guidance cut.   (51-0)

Envision Healthcare Hits 52-Week Low on Q3 Miss, Grim View (Revised)

2017-11-08 zacks
Shares of Envision Healthcare Corp. (EVHC - Free Report) tumbled to a 52-week low of $26.34 during the trading session on Nov 6. The slide is believed to have been driven by poor third-quarter results and a subsequent guidance cut.    (23-0)

Envision Healthcare Hits 52-Week Low on Q3 Loss, Grim View

2017-11-07 zacks
Shares of Envision Healthcare Corp. (EVHC - Free Report) tumbled to a 52-week low of $26.34 during the trading session on Nov 6. The slide is believed to have been driven by poor third-quarter results and a subsequent guidance cut.    (20-0)

What's in the Cards for DaVita (DVA) Stock in Q3 Earnings?

2017-11-07 zacks
DaVita HealthCare Partners Inc. (DVA - Free Report) is expected to report third-quarter fiscal 2017 results on Nov 7, after market close. (14-0)

What's in Store for Madrigal (MDGL) This Earnings Season?

2017-11-06 zacks
Madrigal Pharmaceuticals, Inc. (MDGL - Free Report) is expected to report third-quarter 2017 results on Nov 9, after the market closes.  (70-0)

What's in Store for Catalyst (CPRX) This Earnings Season?

2017-11-06 zacks
Catalyst Pharmaceuticals, Inc. (CPRX - Free Report) is expected to report third-quarter 2017 results on Nov 9, after the market closes.  (140-0)

Amedisys' Arm Buys Intercity Home Care, Boosts U.S. Base

2017-10-03 zacks
Keeping pace with the expected timeline for completion, Amedisys, Inc. (AMED - Free Report) recently announced that its subsidiary Associated Home Care has closed the purchase of Intercity Home Care, a Massachusetts-based personal care provider. Notably, Intercity Home Care’s entire asset base has been taken over by Associated Home Care. (12-1)

Envision Healthcare Continues to Expand Physician Services

2017-09-28 zacks
Envision Healthcare Corp. (EVHC - Free Report) is rapidly transforming its business after its merger with AMSURG last December. The deal created one of the nation's largest physician-staffing companies. Envision Healthcare is now focusing on expanding its core business of physician services (contributing nearly 81% to total revenues) and selling non-core assets. In this vein, it recently announced that it will divest American Medical Response, its medical transportation business, to KKR & Co. (25-0)

Here's Why Mazor Robotics (MZOR) Stock Is Worth a Bet Now

2017-09-26 zacks
Shares of Mazor Robotics Ltd. (MZOR - Free Report) have moved 67.1% up over the last six months, ahead of the S&P 500’s 6.9% gain and the broader industry’s rally of 8.9%. The stock has a market cap of $1.15 billion. (26-0)

STERIS (STE) Rides on Organic Growth, Stiff Contest a Threat

2017-09-26 zacks
On Sep 25, we issued an updated research report on STERIS plc (STE - Free Report) — a manufacturer and marketer of infection prevention, decontamination, microbial reduction along with surgical and gastrointestinal support products and services. The company currently carries a Zacks Rank #3 (Hold). (34-0)

Here's Why You Should Invest in Orthofix International Now

2017-09-26 zacks
Orthofix International N.V. (OFIX - Free Report) has been gaining investor confidence on consistently positive results. The stock has rallied 31.8% year to date, ahead of the S&P 500’s 11.9% gain and the broader industry’s 19.2% rise. (32-0)

Can AngioDynamics (ANGO) Spring a Surprise in Q1 Earnings?

2017-09-26 zacks
AngioDynamics Inc. (ANGO - Free Report) is set to report first-quarter fiscal 2018 (ending Aug 31, 2017) results on Sep 28. Last quarter, the company reported earnings of 19 cents per share, which exceeded the Zacks Consensus Estimate of 16 cents. (105-0)

CUSIP: 023436908